Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(2S,11S,17S,23S,32S,38S,44S)-32-(4-acetamidobutyl)-44-amino-11,23-bis(4-aminobutyl)-38-(3-guanidinopropyl)-45-hydroxy-17-isobutyl-2-methyl-4,7,10,13,16,19,22,25,28,31,34,37,40,43-tetradecaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39,42-tetradecaazapentatetracontan-1-oic acid
ID: ALA4786330
PubChem CID: 162667033
Max Phase: Preclinical
Molecular Formula: C54H97N21O18
Molecular Weight: 1328.50
Molecule Type: Unknown
Associated Items: